Title Credit Series date Member pricesort descending Non-member price
JPHC CE: Preventing HIV in the Adolescent Population with PrEP: The Role of the Nurse Practitioner
1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Preexposure prophylaxis (PrEP) uptake remains low among adolescents and young adults at high risk due to various barriers, such as decreased access to care, human immunodeficiency virus (HIV) stigma, and misinformation. The barriers to the uptake of PrEP among adolescents and young adults are multifaceted and require comprehensive mitigation strategies. Presented is the epidemiology of HIV, pathophysiology, and complications of HIV in adolescents, history of PrEP research, “How to End the HIV Epidemic in the U.S.” plan, reviewing and eliminating barriers to PrEPcare, PrEP curriculum opportunities for the provider, and the role of the nurse practitioner in reducing new HIV diagnoses in adolescents. J pediatr Health Care. (2025) 39, 503−514.
    • 1.00 Contact hours
 05/01/2025 to 06/30/2026 $0.00 $10.00
Navigating the Transition: Supporting Youth Aging Out of Foster Care
0.75 NAPNAP Contact Hour. This continuing education activity is offered for free to NAPNAP Members until 1/31/2026. For non-members, this continuing education activity rate is $15. Youth "age out" of foster care when they reach the legal age of emancipation, typically 18 in most states, though some states extend this to 21. The transition from foster care to independent adulthood can be particularly challenging, often marked by limited resources, social isolation, and a lack of access to essential support systems.
    • 0.75 Contact hours
 04/28/2025 to 04/30/2027 $0.00 $15.00
Clinical Updates in Pediatric Food Allergy Management
Pediatric nurse practitioners and others who care for children with FA will benefit from a review of the immunopathophysiology and diagnosis of immunoglobulin E (IgE)-mediated FA and available therapies and data related to the use of biologic therapy in this disease. Experts will discuss the key aspects of FA management and contextualize the information in nurse practitioners’ role in important patient and caregiver conversations and care.
    • 1.00 Contact hours
 05/15/2025 to 05/15/2026 $0.00 $0.00
Keeping Current in Atopic Diseases
1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session.
    • 1.25 Contact hours
 08/29/2025 to 08/31/2027 $0.00 $0.00
Meningococcal Prevention: Real Stories, Real Questions, and Real Impact

1.0 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
    • 1.00 Contact hours
 01/18/2026 to 01/31/2027 $0.00 $0.00
JPHC CE: Monitoring Vaccine Safety: United States Vaccine Safety Surveillance Systems
1.0 NAPNAP contact hour of which contain 1.0 pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Immunization is an effective public health tool to protect children from hospitalization and death from vaccine-preventable diseases. Vaccine safety monitoring is essential to understand risks of vaccination. The Centers for Disease Control and Prevention closely monitors vaccine safety through multiple surveillance systems, including V-safe, the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. This paper briefly discusses each surveillance system and available evidence that healthcare providers can use to respond to common vaccine concerns. As trusted sources of information about vaccines, pediatric nurses and nurse practitioners need to understand how vaccine safety is monitored, where to access reliable resources about vaccines, and when and where to report adverse events noted after vaccination. J Pediatr Health Care (2026) 40, Issue 1, P174-186.
    • 1.00 Contact hours
 01/01/2026 to 02/28/2027 $0.00 $10.00
JPHC CE: Sexting and Sextortion in Adolescents: Essentials for the PNP
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sexting and sextortion are increasingly common concerns among adolescents, presenting significant challenges for pediatric nurse practitioners (PNPs). Sexting, or digital sharing of self-produced nude or otherwise sexual images, is increasingly seen as a normative part of adolescent sexual exploration, but carries substantial risks, particularly when images are shared non-consensually, by minors, or used as a method of bullying or extortion (“sextortion”). PNPs play a critical role in early identification of any nonconsensual texting and by providing education to adolescents so they may explore their sexuality safely, resist peer pressure, and maintain boundaries. J Pediatr Health Care (2026) 40, Issue 1, P162-173.
    • 1.00 Contact hours
 01/01/2026 to 02/28/2027 $0.00 $10.00
Leucovorin in Autism: An Evidence-Based and Clinically Informed Approach
1.25 NAPNAP Contact Hours of which 1.25 contains pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. This presentation synthesizes the evidence on folinic acid in autism, with an emphasis on advances since 2018 within the context of foundational work. We will examine the pathophysiology of cerebral folate deficiency (CFD), clarify genetic contributors (e.g., FOLR1 and folate-pathway variants), and review clinical testing with folate receptor-α autoantibodies and related labs. Practical treatment guidance will cover formulation selection, dosing and titration, monitoring, adverse effects, and pharmacy/compounding and cost considerations. Taught by a clinician with extensive real-world experience, the presentation highlights where the evidence is strongest and how to implement it. Learners will finish with a concise, evidence-based framework for evaluating and managing CFD in autism within standard practice.
    • 1.25 Contact hours
 11/12/2025 to 11/30/2027 $0.00 $0.00
Influenza 2025-2026: Is Your Pediatric Practice Ready?
1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. As we enter influenza season, pediatric-focused APRNs can increase their knowledge and prepare to counsel families and restore confidence in influenza vaccines. This continuing education presentation will teach providers to balance communication of scientific data and vaccine efficacy with acknowledgment of parental concerns and fears, and help families feel empowered to make the best decisions when it comes to flu prevention.
    • 1.00 Contact hours
 11/14/2025 to 11/30/2026 $0.00 $0.00
JPHC CE: The Landscape of Substance Use in Youth-2024
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. An essential role of pediatric providers is to counsel youth and parents on behavioral health issues, including the use of Alcohol or other drugs (AODs). Although substance use by adolescents has decreased, a significant number of adolescents use AODs, causing those with regular use to be at risk of developing behavioral, physical, and mental health consequences that can continue into adulthood. This article was written to help pediatric providers understand the scope and associated effects of AOD use in their adolescent patients and equip them to counsel, identify, and intervene to reduce the harm to their patients who use AODs. J Pediatr Health Care (2025) Issue 6, p1-12.
    • 1.00 Contact hours
 11/01/2025 to 12/31/2026 $0.00 $10.00
JPHC CE: Trauma Exposure in Migrant Children: Implications for Mental and Physical Health
1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Global migration is a public health crisis of epidemic proportions. Migrants are at risk for a variety of physical and mental health concerns, while having limited access to healthcare. Migrant children are especially vulnerable to experiencing significant trauma, both physical and emotional. Children comprise less than one third of the global population, yet nearly half of migrants are children less than 18 years of age. The United States is home to a significant number of migrant children. Migrant children have a unique set of educational, health, and emotional needs. Given the sheer number of migrant children living in the U.S., pediatric nurse practitioners (PNP) must understand their unique needs and provide evidence-based interventions to help meet these needs. This continuing education article will discuss migrant children in terms of understanding migration, trauma exposure and resultant impact on psychological and physical health, and implications for practice. J Pediatr Health Care (2025) 40, 1-12.
    • 1.50 Contact hours
 09/01/2025 to 10/31/2026 $0.00 $10.00
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting
Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with NAPNAP Partners for Vulnerable Youth. This continuing education activity is offered free for NAPNAP members and nonmembers.
    • 1.50 Contact hours
 10/06/2020 to 08/29/2027 $0.00 $0.00
JPHC CE: Patellofemoral Pain Syndrome in Adolescents: Continuing Education for the Primary Care Provider
1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Patellofemoral Pain Syndrome (PFPS) is a multifactorial complaint of anterior knee pain. Patellofemoral pain typically spreads diffusely across the knee, is notable during weight bearing, and is exacerbated by knee flexion. Patellofemoral pain is often insidious in onset, typically with no identifiable mechanism of injury. Factors believed to contribute to PFPS include overuse, muscular imbalance, joint malalignment, and, rarely, trauma to the joint (Bump & Lewis, 2023). J Pediatr Health Care (2025) 39, 686-694.
    • 1.00 Contact hours
 07/01/2025 to 08/31/2026 $0.00 $10.00
Tick Talk: Digging Deeper into Lyme Disease 2024
1.0 NAPNAP Contact Hour. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course is a recorded presentation for NAPNAP's 2024 National Conference. Lyme disease is the most common vector-borne disease in the U.S., with a childhood peak at five to nine years of age. Pediatric-focused APRNs in both high and low incidence areas may encounter patients in whom Lyme disease is a concern. This presentation will provide an in-depth review of Lyme disease testing and interpretation, discuss when (and when not) to treat and examine the current knowledge regarding prolonged symptoms.
    • 1.00 Contact hours
 06/27/2024 to 06/30/2026 $0.00 $0.00
2025 Pediatric Pharmacology Update
1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. A fast-paced update on pediatric prescribing including newly approved or relabeled pediatric medications, and pediatric pharmacology studies in process. Issues that affect pediatric practice including drug shortages, emerging poisoning hazards, and new guidelines will be discussed.
    • 1.00 Contact hours
 08/29/2025 to 08/31/2027 $0.00 $0.00

Pages